2013•Pharmaceutical MedicineRequires access

Therapeutic drug monitoring

P Honoré

Open publisher page 8 citations

Abstract

Extract Overview Therapeutic drug monitoring is indicated for drugs that have a narrow therapeutic index; in other words, the dose range at which the agent is therapeutic is narrow vs. that above which significant side effects/adverse events of therapy occur. For agents where PK monitoring is possible, and an effective dose range has been defined, this may take the form of assay of drug levels. Where a predictable PD effect is known, this may take the form of assay of a PD marker associated with clinical effect. Indications for PK drug monitoring include: ... Examples of agents where PK assay is currently in clinical use ... Examples of agents where PD effects are monitored Warfarin: narrow therapeutic window between normal INR and INR at a level that risks significant bleeding.

About this research paper

What this paper is about

Extract Overview Therapeutic drug monitoring is indicated for drugs that have a narrow therapeutic index; in other words, the dose range at which the agent is therapeutic is narrow vs. that above which significant side effects/adverse events of therapy occur. For agents where PK monitoring is possible, and an effective dose range has been defined, this may take the form of assay of drug levels. Where a predictable PD effect is known, this may take the form of assay of a PD marker associated with clinical effect. Indications for PK drug monitoring include: ... Examples of agents where PK assay is currently in clinical use ... Examples of agents where PD effects are monitored Warfarin: narrow therapeutic window between normal INR and INR at a level that risks significant bleeding.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Extract Overview Therapeutic drug monitoring is indicated for drugs that have a narrow therapeutic index; in other words, the dose range at which the agent is therapeutic is narrow vs. that above which significant side effects/adverse events of therapy occur. For agents where PK monitoring is possible, and an effective dose range has been defined, this may take the form of assay of drug levels. Where a predictable PD effect is known, this may take the form of assay of a PD marker associated with clinical effect. Indications for PK drug monitoring include: ... Examples of agents where PK assay is currently in clinical use ... Examples of agents where PD effects are monitored Warfarin: narrow therapeutic window between normal INR and INR at a level that risks significant bleeding.

Key concepts: Therapeutic index, Therapeutic drug monitoring, Drug, Therapeutic window, Medicine, Therapeutic effect, Warfarin, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapeutic drug monitoring — Research Paper | ScholarLens